Save $6920
Description
Evrysdi (risdiplam) is a survival of motor neuron 2 (SMN2) splicing modifier used for the treatment of pediatric and adult patients with spinal muscular atrophy (SMA).
Additional information
| Brand | Evrysdi |
|---|---|
| Generic name | Risdiplam for oral solution |
| Form | Oral powder |
| Strength | 0.75mg/ml |
| Packing | 80mL |
| Manufacturer | Roche |
| Documents | Either PO or prescription |
| Storage | 30-40°C temperature |
| Global delivery time | 10-15 days |
| Pay attention | Shipment should be organized from our Company with airlines only (Not FedEx, DHL, EMS, Aramex, UPS), at the specified storage condition along with one data logger. |
Reviews
There are no reviews yet.